Transcranial Doppler measurements of mean blood flow velocity and resistance index are highly repeatable over periods up to 1 week, supporting their use in clinical pharmacology studies.
No takes yet. Share an insight, caveat, or question.
Acceptable short-term repeatability may support transcranial Doppler use in pharmacology studies; leaves open validation for clinical decision-making.
Démolis et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: